JRN73958 is a PI3K/Akt, MAPK, and NF-kappaB inhibitor. JRN73958 decreases LPS/IFNgamma-induced PI3K/Akt, MAPK, and NF-kappaB activity. JRN73958 can be used for the research of leukemia[1][2].
Molecular Weight:
548.59
CAS Number:
[171773-95-8]
Formula:
C36H24N2O4
Target:
NF-kappaB,p38 MAPK,PI3K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted